Teclistamab, Talquetamab, and Elranatamab: Response Rates and Data

Avsnitt

Advances in Thyroid Cancer Treatment
29 aug· GRACEcast - Discussions with the Global Resource for Advancing Cancer Education
Drs. Patel, Sheth, and Weiss discuss emerging data and advances in thyroid cancer treatment.
- Lyssna Lyssna igen Fortsätt Lyssnar...
- Lyssna senare Lyssna senare
Incurable HPV Negative Head and Neck Cancer
21 aug· GRACEcast - Discussions with the Global Resource for Advancing Cancer Education
Drs. Patel, Sheth, and Weiss discuss current treatment options and emerging data in incurable HPV negative head and neck cancer.
- Lyssna Lyssna igen Fortsätt Lyssnar...
- Lyssna senare Lyssna senare
Saknas det avsnitt?

Klicka här för att uppdatera flödet manuellt.
Recurrent/Metastatic HPV Positive Head and Neck Cancer
14 aug· GRACEcast - Discussions with the Global Resource for Advancing Cancer Education
Drs. Patel, Sheth, and Weiss discuss current treatment options and emerging data in recurrent/metastatic HPV positive head and neck cancer.
- Lyssna Lyssna igen Fortsätt Lyssnar...
- Lyssna senare Lyssna senare
Curable HPV Negative Head and Neck Cancer
7 aug· GRACEcast - Discussions with the Global Resource for Advancing Cancer Education
Drs. Patel, Sheth, and Weiss discuss current treatment options and emerging data in curable HPV negative head and neck cancer.
- Lyssna Lyssna igen Fortsätt Lyssnar...
- Lyssna senare Lyssna senare
Curable HPV Positive Head and Neck Cancer
30 jul· GRACEcast - Discussions with the Global Resource for Advancing Cancer Education
Drs. Patel, Sheth, and Weiss discuss current treatment options and emerging data in curable HPV positive head and neck cancer.
- Lyssna Lyssna igen Fortsätt Lyssnar...
- Lyssna senare Lyssna senare
What is a Bone Marrow Transplant?
12 jun· GRACEcast - Discussions with the Global Resource for Advancing Cancer Education
Dr. Marco Ruiz explains the concept of bone marrow transplant, and how it is used in treating blood cancers.
- Lyssna Lyssna igen Fortsätt Lyssnar...
- Lyssna senare Lyssna senare
Q&A: Do People in Rural Communities Have Equal Access to Treatment Options?
10 jun· GRACEcast - Discussions with the Global Resource for Advancing Cancer Education
Drs. Goodman, Phillips, Taneja, and Rajeeve discuss whether a patient's location can affect the treatments they can access and their overall prognosis.
- Lyssna Lyssna igen Fortsätt Lyssnar...
- Lyssna senare Lyssna senare
Q&A: Is my Clinical Trial Affecting my Body's Reaction to the Covid-19 Vaccine?
5 jun· GRACEcast - Discussions with the Global Resource for Advancing Cancer Education
Drs. Goodman, Phillips, Taneja, and Rajeeve discuss how to navigate treatment and Covid vaccination.
- Lyssna Lyssna igen Fortsätt Lyssnar...
- Lyssna senare Lyssna senare
Bispecific Antibodies in Myeloma: Approvals and Clinical Trials
31 maj· GRACEcast - Discussions with the Global Resource for Advancing Cancer Education
Dr. Sridevi Rajeeve discusses current FDA approved bispecific antibodies and ones coming from clinical trials.
- Lyssna Lyssna igen Fortsätt Lyssnar...
- Lyssna senare Lyssna senare
Curative Strategies for Patients with Smoldering Multiple Myeloma
23 maj· GRACEcast - Discussions with the Global Resource for Advancing Cancer Education
Dr. Alankrita Taneja examines data from the CESAR trial, and discusses curative strategies for Smoldering Multiple Myeloma.
- Lyssna Lyssna igen Fortsätt Lyssnar...
- Lyssna senare Lyssna senare
Management of Bispecific Antibodies Side Effects
17 maj· GRACEcast - Discussions with the Global Resource for Advancing Cancer Education
Dr. Sridevi Rajeeve discusses possible side effects from bispecific antibodies, and how to manage them.
- Lyssna Lyssna igen Fortsätt Lyssnar...
- Lyssna senare Lyssna senare
Teclistamab, Talquetamab, and Elranatamab: Response Rates and Data
10 maj· GRACEcast - Discussions with the Global Resource for Advancing Cancer Education
Dr. Sridevi Rajeeve discusses the unprecedented response rates in patients treated with teclistamab, talquetamab, and elranatamab, as well as their clinical trial data.
- Lyssna Lyssna igen Fortsätt Lyssnar...
- Lyssna senare Lyssna senare
Efficacy of Epcoritamab and Glofitamab in Diffuse Large B-Cell Lymphoma
3 maj· GRACEcast - Discussions with the Global Resource for Advancing Cancer Education
Dr. Tycel Phillips examines the efficacy of two medications against diffuse large b-cell lymphoma (DLBCL)
- Lyssna Lyssna igen Fortsätt Lyssnar...
- Lyssna senare Lyssna senare
Barriers to Biomarker Testing: Cost and Insurance
27 apr· GRACEcast - Discussions with the Global Resource for Advancing Cancer Education
Dr. Aakash Desai discusses how to address the issues of cost and insurance approval when obtaining biomarker testing.
- Lyssna Lyssna igen Fortsätt Lyssnar...
- Lyssna senare Lyssna senare
Barriers to Biomarker Testing: Ordering Tests
20 apr· GRACEcast - Discussions with the Global Resource for Advancing Cancer Education
Dr. Aakash Desai emphasizes the importance of physicians ordering biomarker testing for patients with NSCLC
- Lyssna Lyssna igen Fortsätt Lyssnar...
- Lyssna senare Lyssna senare
The Adaura Trial: The Effect on EGFR+ Treatment
15 apr· GRACEcast - Discussions with the Global Resource for Advancing Cancer Education
Dr. Joshua Reuss discusses the ADAURA trial, which suggested Osimertinib as treatment for EGFR+ NSCLC.
- Lyssna Lyssna igen Fortsätt Lyssnar...
- Lyssna senare Lyssna senare
Biomarker Driven Therapy for NSCLC
13 apr· GRACEcast - Discussions with the Global Resource for Advancing Cancer Education
Dr. Aakash Desai discusses the administration of therapy for biomarkers, and how to overcome the gaps in administration, access, and affordability.
- Lyssna Lyssna igen Fortsätt Lyssnar...
- Lyssna senare Lyssna senare
Current Recommendations and Best Practices for Biomarker Testing
11 apr· GRACEcast - Discussions with the Global Resource for Advancing Cancer Education
Dr. Aakash Desai discusses the current recommendations for biomarker testing in patients with NSCLC, as well as best practices.
- Lyssna Lyssna igen Fortsätt Lyssnar...
- Lyssna senare Lyssna senare
The Importance of Biomarker Testing: What is Liquid Biopsy?
9 apr· GRACEcast - Discussions with the Global Resource for Advancing Cancer Education
Dr. Aakash Desai details the importance of biomarker testing, and discusses the method of liquid biopsy to do so.
- Lyssna Lyssna igen Fortsätt Lyssnar...
- Lyssna senare Lyssna senare
Biomarkers in NSCLC
9 apr· GRACEcast - Discussions with the Global Resource for Advancing Cancer Education
Dr. Aakash Desai gives a basic overview of biomarkers, and discusses which ones are important for patients with NSCLC.
- Lyssna Lyssna igen Fortsätt Lyssnar...
- Lyssna senare Lyssna senare
Visa fler

Avsnitt

Advances in Thyroid Cancer Treatment

Incurable HPV Negative Head and Neck Cancer

Recurrent/Metastatic HPV Positive Head and Neck Cancer

Curable HPV Negative Head and Neck Cancer

Curable HPV Positive Head and Neck Cancer

What is a Bone Marrow Transplant?

Q&A: Do People in Rural Communities Have Equal Access to Treatment Options?

Q&A: Is my Clinical Trial Affecting my Body's Reaction to the Covid-19 Vaccine?

Bispecific Antibodies in Myeloma: Approvals and Clinical Trials

Curative Strategies for Patients with Smoldering Multiple Myeloma

Management of Bispecific Antibodies Side Effects

Efficacy of Epcoritamab and Glofitamab in Diffuse Large B-Cell Lymphoma

Barriers to Biomarker Testing: Cost and Insurance

Barriers to Biomarker Testing: Ordering Tests

The Adaura Trial: The Effect on EGFR+ Treatment

Biomarker Driven Therapy for NSCLC

Current Recommendations and Best Practices for Biomarker Testing

The Importance of Biomarker Testing: What is Liquid Biopsy?

Biomarkers in NSCLC